1 munoglobulin G antibodies to OMP B1 in their convalescent sera.

2  titers increased by >/=4-fold in those with convalescent sera.

3 potential of anti-GlcCer antibodies found in convalescent sera.

4                    The findings suggest that convalescent sera alone is not sufficient for providing

5 ape variants from human viruses treated with convalescent sera and from mice that had been previously

6                                              Convalescent sera and sera from other streptococcal dise

7 acaques treated with homologous ZEBOV-Makona convalescent sera died on days 8-9.

8                                              Convalescent sera from 20 cholera patients infected with

9 ps the site IV sequence reacted with all the convalescent sera from 42 SARS patient, but none of the

10 onses, were assessed by Luminex in acute and convalescent sera from 91 EM patients, in serum and syno

11                                              Convalescent sera from cholera patients had a mean vibri

12 t the recombinant E. canis p120 reacted with convalescent sera from dogs with canine ehrlichiosis.

13 e-linked immunosorbent assays of antibody in convalescent sera from mares naturally infected with L.

14 closely related viruses, we tested acute and convalescent sera from nine Thai patients with PCR-confi

15                                        Human convalescent sera from patients infected with B. abortus

16 ng the entire S protein sequence against the convalescent sera from SARS patients and antisera from s

17  by screening the genomic library with swine convalescent sera showing that P102 is expressed in vivo

18  One macaque treated with heterologous SEBOV convalescent sera survived, while the other animals trea

19  by incubating them with human and/or ferret convalescent sera to human H1N1 and H3N2 viruses.

20      The major antigens recognized by murine convalescent sera were F1, V antigen, YopH, YopM, YopD,